Indegene Limited - travel and hospitality in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN L73100KA1998PLC102040 Incorporated 16 October 1998 ROC Bangalore HQ Bangalore, Karnataka, India
Active Listed Public Limited Company travel and hospitality
Data last updated
Market Cap
₹14,313 Cr
INDGN · NSE
Share Price
₹608.95
+2.50% today
Revenue
₹3,510 Cr
FY 2025-26 · +26.3% YoY
EBITDA
₹599 Cr
Margin 17.1%
Net Profit
₹415 Cr
FY 2025-26 · -0.5% YoY
P/E (TTM)
34.6x
P/B 4.6x
ROE
13.9%
ROCE 17.1%
Debt / Equity
0.04
Interest cover 4.1x

About Indegene Limited

Data last updated: 26 September 2026

Indegene Limited is a public limited company based in Bangalore, Karnataka, India. It specialises in consumer and professional services, a part of the broader travel and hospitality sector. Incorporated on 16 October 1998, the company has been in operation for over 28 years.

Registered with ROC Bangalore under CIN L73100KA1998PLC102040. Listed.

Capital: an authorised share capital of ₹80 Cr and a paid-up capital of ₹48.19 Cr. Formerly known as Ndegene Lifesystems Private Limited and Indegene Lifesystems Private Limited. It is led by directors including Pravin Udhyavara Bhadya Rao and Mark Frank Dzialga.

Last AGM: 26 June 2025. Financial statements filed for year ended 31 March 2025. Office: Aspen G4 3Rd Floor Manyata Embassy Business Park Outer Ring Road Nagavara, Bangalore, Karnataka, India – 560045.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹3,510.5 Cr, a growth of 23.64% compared to the previous year. The net worth stands at ₹3,138.7 Cr (up 20% YoY). Total assets are valued at ₹3,573.5 Cr (up 28.05% YoY).

The company has a workforce of approximately 4,628 employees as per the latest available data.

The company is associated with 1 brand - Indegene. As per MCA filings, the company has open charges of ₹85.5 Cr and satisfied charges of ₹25.45 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indegene.com.

Company Details of Indegene Limited
CIN L73100KA1998PLC102040
Registration Number 102040
Incorporation Date 16 October 1998
ROC Bangalore
Listing Status Listed
Company Status Active
Date of Last AGM 26 June 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    Aspen G4 3Rd Floor Manyata Embassy Business Park Outer Ring Road Nagavara, Bangalore, Karnataka, India – 560045
  • Industry
    Travel and Hospitality, Consumer Professional Services
Company report
Indegene Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Indegene Limited report

Financials, compliance, directors, charges, ownership and filings for Indegene Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Indegene Limited

Indegene Limited has undergone 2 name changes throughout its history. The company was previously known as Ndegene Lifesystems Private Limited, and Indegene Lifesystems Private Limited. The current legal name is Indegene Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Indegene Limited Current
Ndegene Lifesystems Private Limited Previous
Indegene Lifesystems Private Limited Previous

CIN History of Indegene Limited

Indegene Limited has 4 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L73100KA1998PLC102040, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L73100KA1998PLC102040 Current
U73100KA1998PTC102040 Previous
U73100MH1998PTC269424 Previous
U73100KA1998PTC032501 Previous
U73100KA1998PLC102040 Previous

Associated Brands with Indegene Limited

Indegene Limited operates one associated brand: Indegene. These brands represent Indegene Limited's diversified market presence and brand portfolio.

Brand Description Website
Suite solutions are provided for payers and healthcare providers. indegene.com

Competitors & Alternatives of Indegene Limited

Brands and companies operating in the same space as Indegene Limited include Zuellig Pharma, IntegriChain, Clinigen and 4 more.

Competitor Description Location Founded
Zuellig Pharma Zuellig Pharma Healthcare access in Asia is enhanced by Zuellig Pharma. Singapore, Singapore, Singapore 1992
IntegriChain IntegriChain Inventory, order and customer relationship management solution for life science suppliers. Philadelphia, United States, United States 2005
Clinigen Clinigen Specialty medicines are supplied via clinical trials and access programs. Burton-on-trent, United Kingdom, United Kingdom 2010
Fishawack Fishawack Fully integrated cross-border services are delivered to global pharmaceutical organizations. Brighton, United Kingdom, United Kingdom 2001
ClearView Healthcare Partners ClearView Healthcare Partners Strategic consulting services are provided to life sciences companies. Newton, United States, United States 2008
Fabtech Fabtech Instruments for biotech, pharmaceutical, and biomedical sectors are manufactured. Mumbai, India, India 2002
Science Group Science Group Technology-based consultancy and product development services are provided. Cambridge, United Kingdom, United Kingdom 1995

Auditor Details of Indegene Limited

Indegene Limited is audited by BSR & CO LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
BSR & CO LLP Locked Locked Locked
Premium access

Complete auditor history for Indegene Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Indegene Limited

Indegene Limited is currently managed by 11 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Pravin Udhyavara Bhadya Rao Director 08 Jun 2022 4 Years 3 Months Current
Mark Frank Dzialga Nominee Director 16 Apr 2021 5 Years 5 Months Current
Ashish Gupta Director 28 Apr 2022 4 Years 4 Months Current
Rajesh Bhaskaran Nair Director 16 Oct 1998 27 Years 11 Months Current
Manish Gupta Whole-Time Director 11 Feb 2000 26 Years 7 Months Current
Sanjay S Parikh Director 29 Jan 2002 24 Years 7 Months Current
Showing 6 of 11 current directors. View all directors

Financials of Indegene Limited FY 2025-26 filings available

Indegene Limited reported revenue of ₹3,510.5 Cr (up 23.64% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹3,510 Cr
+23.6% YoY
EBITDA
₹599 Cr
+12.1% YoY
Profit After Tax
₹415 Cr
-0.5% YoY
Net Worth
₹3,139 Cr
+20.0% YoY
Total Assets
₹3,574 Cr
+28.1% YoY
Total Debt
₹144 Cr
+42.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue3,5102,8392,5902,3061,665966643
Revenue growth+26.3%+6.0%+13.9%+34.1%+76.8%+33.2%+18.3%
EBITDA59953441439624016037.88
EBITDA margin+17.1%+18.8%+16.0%+17.2%+14.4%+16.6%+5.9%
Profit before tax52553945936322619513.68
Net profit415416335266192147(66.21)
Net profit margin+11.8%+14.7%+12.9%+11.5%+11.5%+15.2%-10.3%
EPS (₹)16.6816.9815.1712.01938.81954.66(40.25)
Balance sheet
Total assets3,5742,7912,0261,738935417476
Net worth3,1392,6161,4291,064764325211
Total debt14410249050265.7551.38168
Cash & bank38237519185.80517140180
Net working capital472705474369592280294
Cash flow
Cash from operations65144250813029717222.27
Cash from investing(508)(677)(326)(896)(158)(81.03)(15.78)
Cash from financing(82.60)288(66.20)333233(132)136
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue1,0631,003942804761756720687
Revenue growth (YoY)+39.7%+32.8%+30.8%+17.1%+12.5%+12.3%+7.0%+8.0%
Other income29.0010.8019.4019.7022.1025.6037.7021.40
EBITDA174143160141155148132126
EBITDA margin+16.4%+14.3%+16.9%+17.5%+20.4%+19.5%+18.3%+18.4%
Depreciation44.1041.8039.6023.4021.6020.7020.0019.40
Interest6.407.204.603.803.703.103.204.00
Profit before tax153105135133152149146124
Tax36.5025.4031.8031.0035.7031.7036.6032.40
Net profit11679.7010310211611811091.70
EPS (₹)4.813.304.264.234.824.884.553.80
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,2211,0941,0461,006837511334
Revenue growth+6.5%+4.1%+6.0%+23.9%+69.5%+34.9%+27.3%
EBITDA24818016817816911742.20
EBITDA margin+20.3%+16.5%+16.1%+17.7%+20.2%+22.9%+12.6%
Profit before tax28123818117717015945.50
Net profit21217712513013313060.61
Net profit margin+17.4%+16.2%+11.9%+13.0%+15.9%+25.4%+18.1%
EPS (₹)8.817.576.215.88663.50882.67211.33
Balance sheet
Total assets2,2301,9741,035881720290368
Net worth2,0801,888954795650254312
Total debt69.8027.2038.0051.1043.8023.0046.90
Cash & bank13016415.6054.0038.8018.2036.00
Net working capital32153932737828513555.60
Cash flow
Cash from operations34612917681.9038.2053.3089.60
Cash from investing(270)(824)(189)(51.00)(267)(34.10)(51.10)
Cash from financing(62.60)717(15.80)(16.90)245(37.10)(18.50)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue341368290307256267287282
Revenue growth (YoY)+33.3%+38.1%+1.2%+8.9%-1.2%-2.1%+10.3%+8.1%
Other income33.906.1022.6017.5032.1035.2022.3022.40
Total expenses280265252236219227235235
EBITDA60.2010337.7070.6036.7039.6051.9046.40
EBITDA margin+17.7%+28.0%+13.0%+23.0%+14.4%+14.8%+18.1%+16.5%
Depreciation11.4010.909.508.607.306.906.506.20
Interest2.703.101.802.001.701.501.601.60
Profit before tax80.0095.2049.0077.5059.8066.4066.1061.00
Tax20.1023.1014.2017.6014.7012.2016.2016.20

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 26 Sep 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue1,0631,003942804761756720687
Revenue growth (YoY)+39.7%+32.8%+30.8%+17.1%+12.5%+12.3%+7.0%+8.0%
Other income29.0010.8019.4019.7022.1025.6037.7021.40
EBITDA174143160141155148132126
EBITDA margin+16.4%+14.3%+16.9%+17.5%+20.4%+19.5%+18.3%+18.4%
Depreciation44.1041.8039.6023.4021.6020.7020.0019.40
Interest6.407.204.603.803.703.103.204.00
Profit before tax153105135133152149146124
Tax36.5025.4031.8031.0035.7031.7036.6032.40
Net profit11679.7010310211611811091.70
EPS (₹)4.813.304.264.234.824.884.553.80
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue3,5102,8392,5902,3061,665966643
Revenue growth+26.3%+6.0%+13.9%+34.1%+76.8%+33.2%+18.3%
Other income72.0010717058.0025.8967.263.98
Total expenses2,9122,3052,1751,9101,425806605
Employee cost2,1981,8151,6521,4651,014536370
EBITDA59953441439624016037.88
EBITDA margin+17.1%+18.8%+16.0%+17.2%+14.4%+16.6%+5.9%
Depreciation12680.2076.1059.8033.4525.5519.34
Interest19.3022.0049.4031.305.966.968.84
Profit before tax52553945936322619513.68
Tax12413312296.9063.6845.7826.12
Net profit415416335266192147(66.21)
Net profit margin+11.8%+14.7%+12.9%+11.5%+11.5%+15.2%-10.3%
EPS (₹)16.6816.9815.1712.01938.81954.66(40.25)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital48.1047.9044.4044.300.350.31316
Reserves & surplus3,0902,5671,3851,020764324(105)
Shareholders' funds (net worth)3,1392,6161,4291,064764325211
Minority interest0.000.000.000.000.008.5889.08
Secured loans0.000.0039339425.5324.76136
Unsecured loans14410296.2010840.2226.6231.71
Total debt14410249050265.7551.38168
Total liabilities3,5742,7912,0261,738935417476
Assets
Gross block2,3541,096995863271191259
Net block1,81267864666413885.91119
Capital work in progress11.803.600.000.000.000.000.00
Investments1,1001,2907966141200.0013.16
Inventories0.000.000.000.000.000.000.00
Sundry debtors982751648642444285224
Cash & bank balances38237519185.80517140180
Loans & advances15511415510748.9534.0013.64
Total current assets1,5191,2409948351,010459418
Total current liabilities1,047535520466419179124
Net working capital472705474369592280294
Total assets3,5742,7912,0261,738935417476
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash24118973.6050613317431.01
Net cash from operating activities65144250813029717222.27
Net cash from investing activities(508)(677)(326)(896)(158)(81.03)(15.78)
Net cash from financing activities(82.60)288(66.20)333233(132)136
Net change in cash59.8052.40115(433)373(40.50)143
Closing cash38237519185.80517140180
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+23.6%+9.6%+12.3%+38.5%+72.3%+50.3%+16.2%
EBITDA growth+12.1%+29.0%+4.6%+65.0%+49.6%+323.5%-9.9%
PBT growth-2.7%+17.6%+26.3%+60.3%+16.1%+1326.8%-46.8%
Net income growth-0.5%+24.3%+25.9%+38.6%+30.5%+9998.0%-
Revenue CAGR (3Y)+15.0%+19.5%+38.9%+53.1%+44.4%--
EBITDA CAGR (3Y)+14.8%+30.6%+37.2%+118.7%+78.8%--
Profitability & leverage
Net income margin+11.4%+14.3%+13.0%+11.5%+9.8%+15.5%-1.9%
Return on capital employed+17.1%+23.3%+27.0%+29.5%+41.6%+59.2%0.0%
Return on net worth+13.9%+20.1%+27.0%+29.1%+34.9%+133.9%0.0%
Debt / equity0.040.150.400.310.110.410.65
Long-term debt / equity0.030.120.350.290.070.140.14
Interest cover4.094.8414.619.312.895.1647.68
Efficiency & per share
Fixed asset turnover2.042.722.794.067.204.292.84
Inventory turnover0.000.000.000.000.000.000.00
Debtors turnover4.054.064.014.254.563.804.10
EPS (₹)16.6816.9815.1712.01938.81954.66(40.25)
Dividend per share (₹)2.252.000.000.000.000.000.00
Book value per share (₹)130.49109.1764.3748.034,352.712,073.47(668.89)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue341368290307256267287282
Revenue growth (YoY)+33.3%+38.1%+1.2%+8.9%-1.2%-2.1%+10.3%+8.1%
Other income33.906.1022.6017.5032.1035.2022.3022.40
Total expenses280265252236219227235235
EBITDA60.2010337.7070.6036.7039.6051.9046.40
EBITDA margin+17.7%+28.0%+13.0%+23.0%+14.4%+14.8%+18.1%+16.5%
Depreciation11.4010.909.508.607.306.906.506.20
Interest2.703.101.802.001.701.501.601.60
Profit before tax80.0095.2049.0077.5059.8066.4066.1061.00
Tax20.1023.1014.2017.6014.7012.2016.2016.20
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,2211,0941,0461,006837511334
Revenue growth+6.5%+4.1%+6.0%+23.9%+69.5%+34.9%+27.3%
Other income78.3090.4050.3036.8027.8063.6020.10
Total expenses972913878828668394292
Employee cost795759752701526273187
EBITDA24818016817816911742.20
EBITDA margin+20.3%+16.5%+16.1%+17.7%+20.2%+22.9%+12.6%
Depreciation36.3026.2031.1031.7023.6017.6013.40
Interest8.706.206.606.403.003.503.40
Profit before tax28123818117717015945.50
Tax69.5057.2042.7046.4037.2026.9013.80
Net profit21217712513013313060.61
Net profit margin+17.4%+16.2%+11.9%+13.0%+15.9%+25.4%+18.1%
EPS (₹)8.817.576.215.88663.50882.67211.33
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital48.1047.9044.4044.300.400.30316
Reserves & surplus2,0321,839909751650254(3.40)
Shareholders' funds (net worth)2,0801,888954795650254312
Secured loans0.000.000.000.000.000.0021.40
Unsecured loans69.8027.2038.0051.1043.8023.0025.50
Total debt69.8027.2038.0051.1043.8023.0046.90
Total liabilities2,2301,9741,035881720290368
Assets
Gross block25318317518714999.4072.50
Net block11352.8056.1078.3072.0040.6031.30
Capital work in progress11.803.600.000.000.000.000.00
Investments1,31897562440020383.40251
Inventories0.000.000.000.000.000.000.00
Sundry debtors28841837840135017559.70
Cash & bank balances13016415.6054.0038.8018.2036.00
Loans & advances15513311979.3026.3024.6022.80
Total current assets573715513534415218118
Total current liabilities25217618515613082.5062.90
Net working capital32153932737828513555.60
Total assets2,2301,9741,035881720290368
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash35.2013.2041.8027.8011.6029.509.50
Net cash from operating activities34612917681.9038.2053.3089.60
Net cash from investing activities(270)(824)(189)(51.00)(267)(34.10)(51.10)
Net cash from financing activities(62.60)717(15.80)(16.90)245(37.10)(18.50)
Net change in cash13.3022.00(28.60)14.0016.20(17.90)20.00
Closing cash13016415.6054.0038.8018.2036.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+11.6%+4.6%+4.0%+20.2%+63.7%+52.8%+18.5%
EBITDA growth+37.5%+7.4%-5.6%+5.5%+44.4%+176.8%-19.8%
PBT growth+18.0%+32.1%+2.3%+3.9%+6.7%+250.1%-23.0%
Net income growth+19.9%+41.9%-4.4%-1.9%+2.1%+114.4%+19.4%
Revenue CAGR (3Y)+6.7%+9.3%+27.0%+44.3%+43.7%--
EBITDA CAGR (3Y)+11.7%+2.3%+12.9%+61.5%+47.5%--
Profitability & leverage
Net income margin+17.4%+16.6%+13.2%+13.0%+15.9%+25.9%+9.5%
Return on capital employed+13.8%+16.3%+19.5%+22.9%+34.2%+47.7%+26.3%
Return on net worth+10.7%+12.8%+15.8%+18.0%+29.4%+96.4%+67.5%
Debt / equity0.020.020.050.070.070.120.14
Long-term debt / equity0.020.010.040.050.050.050.03
Interest cover4.114.024.824.382.073.5311.81
Efficiency & per share
Fixed asset turnover5.606.105.775.976.735.956.17
Inventory turnover0.000.000.000.000.000.000.00
Debtors turnover3.452.752.692.683.194.356.09
EPS (₹)8.817.576.215.88663.50882.67211.33
Dividend per share (₹)2.252.000.000.000.000.000.00
Book value per share (₹)86.4978.8042.9635.913,250.001,692.67(20.67)
Want more history and ratios?
You're viewing the latest exchange-filed financials for Indegene Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Indegene Limited

As per the shareholding pattern for the quarter ended Jun 2026, promoters hold 0.00%, foreign institutional investors hold 9.90%, domestic institutional investors hold 8.80%, retail and other public shareholders hold 81.30% of Indegene Limited.

DII (Domestic Institutional): 8.80%FII (Foreign Institutional): 9.90%Retail & Others: 81.30%
Jun 2026
QUARTER
8.80% DII (Domestic Institutional)
9.90% FII (Foreign Institutional)
81.30% Retail & Others
Public holding - history
Now 100.00% · Jun 2026High 100.00% · Sep 2025Low 100.00% · Sep 2025
99%99.3%99.5%99.8%100%Sep 2025Dec 2025Mar 2026Jun 2026Sep 2025: 100.00%Dec 2025: 100.00%Mar 2026: 100.00%Jun 2026: 100.00%100.00%100.00%
Shareholding trend - last 6 quarters
Jun 2026Mar 2026Dec 2025Sep 2025
Promoters0.00%0.00%0.00%0.00%
Public100.00%100.00%100.00%100.00%

Charges & Borrowings of Indegene Limited

Open charges
₹85.5 Cr
Satisfied charges
₹25.45 Cr
Breakdown by lending institutions
Others₹40.50 Cr
Jp Morgan Chase Bank, N.A.₹15.00 Cr
Citi Bank N.A.₹15.00 Cr
The Hongkong and Shanghai Banking Corporation Limited₹15.00 Cr
Latest charge details
DateLenderAmountStatus
27 Sep 2024 Jp Morgan Chase Bank, N.A. ₹15 Cr Open
29 Aug 2022 Citi Bank N.A. ₹15 Cr Open
26 May 2022 Others ₹10 Cr Open
20 Dec 2021 The Hongkong and Shanghai Banking Corporation Limited ₹15 Cr Open
21 Jun 2012 Others ₹30.5 Cr Open

Total charge records: 9 View all charges

Employees and EPFO Compliance at Indegene Limited

Indegene Limited has a workforce of 4,628 employees as of Apr 07, 2024.

Employee count
4,628
Active EPFO establishments
1
Employee growth
-2.88%
Premium access

Employee and EPFO history for Indegene Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Indegene Limited

Premium access

GST registrations and filing compliance for Indegene Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Indegene Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Indegene Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Indegene Limited

Premium access

MSME payment history for Indegene Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Indegene Limited

Premium access

Corporate group structure for Indegene Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Indegene Limited

Premium access

MCA filings and documents for Indegene Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Indegene Limited

Directors
23 Jan 2026
Neeraj Bharadwaj was appointed as a Director on 23 Jan 2026 & has been associated with this company since 8 months 4 days.
Directors
22 Jan 2026
Jill Mary De Simone was appointed as a Additional Director on 22 Jan 2026 & has been associated with this company since 8 months 5 days.
Activity
26 Jun 2025
Indegene Limited last Annual general meeting of members was held on 26 Jun 2025 as per latest MCA records.
Activity
31 Mar 2025
Indegene Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
27 Sep 2024
A charge with Jp Morgan Chase Bank, N.A. amounted to Rs. 15.00 Cr with Charge ID 100990051 was registered on 27 Sep 2024.
Charges
24 May 2024
A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 15.00 Cr registered on 20 Dec 2021 with Charge ID 100523668 was modified on 24 May 2024.

Frequently Asked Questions about Indegene Limited

Indegene Limited is an active public limited company in the travel and hospitality sector based in Bangalore, Karnataka, India. It was incorporated on 16 October 1998 (28+ years old) and is registered under CIN L73100KA1998PLC102040. The company has 4,628 employees.

Indegene Limited reported revenue of ₹3,510.5 Cr for FY 2025-26 (up 23.64% YoY) based on consolidated financials.

The current directors of Indegene Limited are:

The primary industry of Indegene Limited is travel and hospitality. The company specifically operates in consumer professional services. The company is currently active in this sector.

Yes, Indegene Limited is a listed company.

Indegene Limited can be reached at the registered office: Aspen G4 3Rd Floor Manyata Embassy Business Park Outer Ring Road Nagavara, Bangalore, Karnataka, India – 560045, or through the website indegene.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available